Industries > Pharma > Cellular Immunotherapy Market Report 2021-2031
Cellular Immunotherapy Market Report 2021-2031
Forecasts by Therapy Type (CAR-T Cell Therapy, NK Cell Therapy, TIL Therapy, Others), by Products & Services (Cellular Immunotherapy Products, Cellular Immunotherapy Services), by Testing Assays Type (Bioanalytics, Characterization, Biosafety), by Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cellular Immunotherapy Companies AND COVID-19 Recovery Scenarios
Global Cellular Immunotherapy Market Outlook
According to Visiongain analysis, global cellular immunotherapy market was valued at US$xx billion in 2020 and is expected to grow at a CAGR of xx% during the forecast period 2021-2031 to reach US$xx billion by 2031.
Key Questions Answered by this Report:
• What is the current size of the overall global cellular immunotherapy market? How much will this market be worth from 2021 to 2031?
• What are the main drivers and restraints that will shape the overall cellular immunotherapy market over the next ten years?
• What are the main segments within the overall cellular immunotherapy market?
• How much will each of these segments be worth for the period 2021 to 2031?
• How will the composition of the market change during that time, and why?
• What factors will affect that industry and market over the next ten years?
• What are the largest national markets for the world cellular immunotherapy?
• What is their current status and how will they develop over the next ten years?
• What are their revenue potentials to 2031?
• How will political and regulatory forces influence regional markets?
• How will market shares of the leading national markets change by 2031, and which geographical region will lead the market in 2031?
• Who are the leading companies and what are their activities, results, developments and prospects?
• What are the leading cellular immunotherapy? What are their revenues and latest developments?
• What are some of the most prominent cellular immunotherapy currently in development?
• What are the main trends that will affect the world cellular immunotherapy market between 2021 and 2031?
• What are the main strengths, weaknesses, opportunities and threats for the market?
• What are the social, technological, economic and political influences that will shape that industry over the next ten years?
• How will the global cellular immunotherapy market evolve over the forecasted period, 2021 to 2031?
• What will be the main commercial drivers for the market from 2021 to 2031?
• How will market shares of prominent national markets change from 2021, and which countries will lead the market in 2031, achieving highest revenues and fastest growth?
• How will that industry evolve between 2021 and 2031, especially in R&D?
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
To access the data contained in this document please email contactus@visiongain.com
Rising demand for advanced therapies for cancer treatment is boosting the growth of global market. Find out why.
Immunotherapy, along with chemotherapy, surgery, and radiotherapy, has started to emerge as the “fourth pillar” of treatment for cancer in the last decade. Immunotherapy has transformed cancer treatment and revitalized tumor immunology. Several types of immunotherapy, including adoptive cell transfer (ACT) and immune checkpoint inhibitors (ICIs), have produced long-term clinical responses in cancer patients. The initial focus of CAR-T-cell therapies was primarily on ALL, the most common childhood cancer. The Food and Drug Administration (FDA) approved two CAR-T-cell therapies in 2017, one for the treatment of children with acute lymphoblastic leukemia (ALL) and the other for adults with advanced lymphomas.
Discover sales predictions for the global cellular immunotherapy market and submarkets
Over the last few years, cellular immunotherapy has gained widespread attention due to its high efficiency and adoption for the treatment of patients with severe cancer. Along with revenue prediction for the overall world market, there are 4 segmentations of the Cellular Immunotherapy market, with forecasts for 4 Therapy Type, 2 Products & Services, 3 Testing Assay Types, each forecasted at a global, regional, and country level, along with COVID-19 impact recovery pattern analysis for all segments.
Need industry data? Please contact us today.
Who are the leading players analysed in the market?
• Novartis AG
• Gilead Sciences, Inc.
• Adicet Bio
• GlaxoSmithKline plc.
• Pfizer Inc.
• F. Hoffmann-La Roche Ltd.
• Iovance Biotherapeutics, Inc.
• Tessa Therapeutics Ltd.
• Inovio Pharmaceuticals, Inc.
• AstraZeneca
• Adaptimmune Therapeutics plc.
• Atara Biotherapeutics, Inc.
• Bristol-Myers Squibb Company
• APAC Biotech
• JW shinyak (JW CreaGene)
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Cellular Immunotherapy Market Report 2021-2031: Forecasts by Therapy Type (CAR-T Cell Therapy, NK Cell Therapy, TIL Therapy, Others), by Products & Services (Cellular Immunotherapy Products, Cellular Immunotherapy Services), by Testing Assays Type (Bioanalytics, Characterization, Biosafety), by Indication (B-cell Malignancies, Prostate Cancer, Liver Cancer, Renal Cell Carcinoma, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Cellular Immunotherapy Companies AND COVID-19 Recovery Scenarios. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1 Introduction to Cellular Immunotherapy Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecast Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers for Cellular Immunotherapy Market
3.1.1 Increasing Prevalence of Cancer is driving the Market
3.1.2 Increasing Geriatric Population around the World is Boosting the Demand for Cellular Immunotherapy
3.1.3 Development of Advanced Cellular Immunotherapy is Driving the Cellular Immunotherapy Market
3.1.4 Support from National Cancer Institute for Immunotherapy is estimated to propel the Market Growth
3.2 Restraints for Cellular Immunotherapy Market
3.2.1 Stringent Regulations Associated with Product Development Hinders the Market Growth
3.2.2 High Costs of Cellular Immunotherapy Limits the Market Growth
3.2.3 Complex Supply Chain and Manufacturing Could limit the Entry of New Players
3.3 Opportunities for Cellular Immunotherapy Market
3.3.1 Increasing Demand for the Advanced Cellular Immunotherapy for Cancer Treatment Is Projected to Boost the Market Growth
3.3.2 Mergers, Agreements, and Acquisitions by the Market Players is a Major Trend Witnessed in the Market
3.4 Challenges for Cellular Immunotherapy Market
3.4.1 Adverse Effects associated With Cellular Immunotherapy could Limit its Adoption
3.4.2 Reimbursement Issues for the Advanced Cellular Immunotherapy
3.5 SWOT Analysis for Cellular Immunotherapy Market
3.5.1 Strengths: Cellular Immunotherapy Market
3.5.1.1 Rising Popularity of Cellular Immunotherapy for Cancer Treatment
3.5.1.2 Escalating Clinical-research Infrastructure in Asia Pacific Region
3.5.2 Weaknesses: Cellular Immunotherapy Market
3.5.2.1 Complexity of Cellular Immunotherapies
3.5.2.2 Changing Regulatory Requirements
3.5.3 Opportunities: Cellular Immunotherapy Market
3.5.3.1 Increase in Collaborations between Biopharmaceutical Companies and Academic Research Centers
3.5.3.2 Advantages of CAR-T-Therapy for the Treatment of Liquid Tumors
3.5.4 Threats: Cellular Immunotherapy Market
3.5.4.1 Availability of Alternative Treatment Options
3.5.4.2 Ethical Issues Associated with Cellular Immunotherapy
3.6 Porter’s Five Forces Analysis: Cellular Immunotherapy Market
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyer: Low
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis: Cellular Immunotherapy Market
3.7.1 Political Factors Impacting Cellular Immunotherapy Market
3.7.2 Economic Factors Impacting Cellular Immunotherapy Market
3.7.3 Social Factors Impacting Cellular Immunotherapy Market
3.7.4 Technological Factors Impacting Cellular Immunotherapy Market
4 COVID-19 Impact: Global Cellular Immunotherapy Market
4.1 Global Cellular Immunotherapy Market Forecast, 2021-2031
4.2 COVID-19 Impact Overview
4.3 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
4.4 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
4.5 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
4.6 "L" Shaped Recovery - Rapid Decline - Then Slow Growth
5 Global Cellular Immunotherapy Market Size Forecast 2021-2031 by Therapy Type
5.1 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031
5.1.1 CAR-T Cell Therapy is the Largest Revenue Grossing Segment
5.1.2 Recovery Forecasts (V, U, W, L)
5.2 Global NK (Natural Killer) Cell Therapy Segment: Revenue Forecast 2021-2031
5.2.1 NK Cell Lines Offer a Robust Cytotoxicity against Cancer Cells
5.2.2 Recovery Forecasts (V, U, W, L)
5.3 Global Tumor-Infiltrating Lymphocyte (TIL) Therapy Segment: Revenue Forecast 2021-2031
5.3.1 TIL Therapy is a Promising form of Adoptive Cellular Immunotherapy
5.3.2 Recovery Forecasts (V, U, W, L)
5.4 Global Others Segment: Revenue Forecast 2021-2031
5.4.1 Promising Engineered T-Cell Receptor (TCR) and Dendritic Cell (DC)-based Therapies are expected to boost the Other Cell Therapy Segment Growth
5.4.2 Recovery Forecasts (V, U, W, L)
6 Cellular Immunotherapy Market by Product and Services Forecast, 2021-2031
6.1 Global Cellular Immunotherapy Product Segment Market Forecast, 2021-2031
6.1.1 Cellular Immunotherapy Product Segment is showing the Highest CAGR during the Forecast Period
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Global Cellular Immunotherapy Services Segment Market Forecast, 2021-2031
6.2.1 Rising Investment in Cell-Based Therapies R&D is driving the Cellular Immunotherapy Services Segment
6.2.2 Recovery Scenarios (V, U, W, L)
7 Cellular Immunotherapy Market by Testing Assays Type Forecast, 2021-2031
7.1 Bioanalytics Segment Market Forecast, 2021-2031
7.1.1 Largest-Revenue Growing Segment in the Market
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 Characterization Segment Market Forecast, 2021-2031
7.2.1 Second-Largest Revenue Generating Segment
7.2.2 Recovery Scenarios (V, U, W, L)
7.3 Biosafety Segment Market Forecast, 2021-2031
7.3.1 Well-defined Regulations for the Cellular Therapies in the Developed Countries Is Expected To Drive the Market Growth
7.3.2 Recovery Scenarios (V, U, W, L)
8 Global Cellular Immunotherapy Market Size Forecast 2021-2031 by Indication
8.1 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031
8.1.1 B-cell Malignancies is the Largest Revenue Grossing Segment
8.1.2 Recovery Forecasts (V, U, W, L)
8.2 Global Prostate Cancer Segment: Revenue Forecast 2021-2031
8.2.1 sipuleucel-T (Provenge) has been Approved by the US FDA for the Treatment of Prostate Cancer
8.2.2 Recovery Forecasts (V, U, W, L)
8.3 Global Liver Cancer Segment: Revenue Forecast 2021-2031
8.3.1 Liver Cancer Segment is Expected to Grow at a Lucrative Growth Rate
8.3.2 Recovery Forecasts (V, U, W, L)
8.4 Global Renal Cell Carcinoma Segment: Revenue Forecast 2021-2031
8.4.1 Growing Investment in Cellular Immunotherapy for the Treatment of Renal Cell Carcinoma is projected to Drive the Segment Growth
8.4.2 Recovery Forecasts (V, U, W, L)
8.5 Global Others Segment: Revenue Forecast 2021-2031
8.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Others Segment Growth
8.5.2 Recovery Forecasts (V, U, W, L)
9 National Cellular Immunotherapy Market Forecast, 2021-2031
9.1 Global Cellular Immunotherapy Market by Region Forecast 2021-2031
9.1 Recovery Scenarios (V, U, W, L)
10 North America Cellular Immunotherapy Market, 2021-2031
10.1 North America is the Largest Revenue Grossing Region in the Global Market
10.2 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.3 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.4 North America Cellular Immunotherapy Market Forecast by Product & Service
10.5 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.6 North America Cellular Immunotherapy Market Forecast by Indication
10.7 Recovery Scenarios (V, U, W, L): North America Market
10.7.1 V-Shaped Recovery
10.7.1.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.1.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.1.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.1.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.1.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.2 U-Shaped Recovery
10.7.2.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.2.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.2.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.2.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.2.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.3 W-Shaped Recovery
10.7.3.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.3.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.3.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.3.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.3.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.4 L-Shaped Recovery
10.7.4.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.4.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.4.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.4.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.4.5 North America Cellular Immunotherapy Market Forecast by Indication
10.8 U.S. Cellular Immunotherapy Market Forecast, 2021-2031
10.8.1 Presence of Leading Players is a Major factor driving the U.S. Cellular Imunotherapy Market
10.8.2 Presence of Highly Developed Healthcare Infrastructure
10.9 Canada Cellular Immunotherapy Market Forecast, 2021-2031
10.9.1 Canada Market Anticipated To Witness the Fastest Growth in the North America Region
10.9.2 Growing Canadian research collaborations determined to Provide Infrastructure for Cell-Based Therapy Research
11 Europe Cellular Immunotherapy Market, 2021-2031
11.1 Second Largest Market in the Global Market
11.2 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.3 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.4 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.5 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.6 Europe Cellular Immunotherapy Market Forecast by Indication
11.7 Recovery Scenarios (V, U, W, L): Europe Market
11.7.1 V-Shaped Recovery
11.7.1.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.1.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.1.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.1.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.1.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.2 U-Shaped Recovery
11.7.2.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.2.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.2.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.2.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.2.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.3 W-Shaped Recovery
11.7.3.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.3.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.3.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.3.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.3.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.4 L-Shaped Recovery
11.7.4.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.4.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.4.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.4.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.4.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.8 Germany Cellular Immunotherapy Market Forecast, 2021-2031
11.8.1 Growing Geriatric Population In This Region Is Expected To Boost The Regional Market Growth
11.8.2 Rising Focus on CAR-T Cell and NK Cell Therapies R&D in Germany
11.9 UK Cellular Immunotherapy Market Forecast, 2021-2031
11.9.1 Presence of Well-Developed R&D Infrastructure
11.9.2 Rise in Number of Treatment Centers in the UK
11.10 France Cellular Immunotherapy Market Forecast, 2021-2031
11.10.1 Growing Demand for Advanced Healthcare Services
11.10.2 Rising Preference for France for Cellular Therapy R&D and Manufacturing by Leading Players
11.11 Italy Cellular Immunotherapy Market Forecast, 2021-2031
11.11.1 Pharmaceutical Manufacturing Hub
11.11.2 Growing Acceptance of Cellular Therapies for the Treatment of Cancer in Italy is projected to drive the Market Growth
11.12 Spain Cellular Immunotherapy Market Forecast, 2021-2031
11.12.1 Demand for Drugs Is Influenced By the Growth of the Pharmaceutical Industry
11.12.2 Spanish Economy Is Growing Strong
11.13 Russia Cellular Immunotherapy Market Forecast, 2021-2031
11.13.1 Growing Government Support for the Development of Advanced Cancer Therapies
11.13.2 Unmet Pharmaceutical Needs
11.14 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031
11.14.1 Increasing Prevalence of Cancer
12 Asia Pacific Cellular Immunotherapy Market, 2021-2031
12.1 Asia Pacific is the Fastest Growing Market
12.2 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.3 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.4 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.5 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.6 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7 Recovery Scenarios (V, U, W, L): APAC Market
12.7.1 V-Shaped Recovery
12.7.1.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.1.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.1.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.1.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.1.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.2 U-Shaped Recovery
12.7.2.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.2.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.2.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.2.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.2.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.3 W-Shaped Recovery
12.7.3.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.3.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.3.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.3.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.3.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.4 L-Shaped Recovery
12.7.4.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.4.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.4.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.4.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.4.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.8 Japan Cellular Immunotherapy Market Forecast, 2021-2031
12.8.1 Japan Accounted For the Largest Market Share in the Asia Pacific Region
12.8.2 Rising Number of Product Approval is Expected to Drive the Market Growth
12.9 China Cellular Immunotherapy Market Forecast, 2021-2031
12.9.1 Strategic Initiatives Undertaken by the Market Players
12.9.2 Increasing Healthcare Spending In China
12.10 India Cellular Immunotherapy Market Forecast, 2021-2031
12.10.1 Developing Healthcare Infrastructure
12.10.2 Increasing Prevalence of Cancer
12.11 Australia Cellular Immunotherapy Market Forecast, 2021-2031
12.11.1 Government Programs to Expand Access to Quality Healthcare
12.11.2 Launch of Cell-based Therapies in Australia is Projected to Boost the Market Growth
12.12 South Korea Cellular Immunotherapy Market Forecast, 2021-2031
12.12.1 Growing Healthcare Awareness among People
12.12.2 Rising Cancer Incidence is Expected to Drive theSouth Korea Market
12.13 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031
12.13.1 Rising Disposable Income
13 Latin America Cellular Immunotherapy Market, 2021-2031
13.1 Latin America Cellular Immunotherapy Market
13.2 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.3 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.4 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.5 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.6 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7 Recovery Scenarios (V, U, W, L): Latin America Market
13.7.1 V-Shaped Recovery
13.7.1.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.1.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.1.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.1.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.1.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.2 U-Shaped Recovery
13.7.2.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.2.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.2.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.2.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.2.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.3 W-Shaped Recovery
13.7.3.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.3.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.3.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.3.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.3.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.4 L-Shaped Recovery
13.7.4.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.4.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.4.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.4.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.4.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.8 Brazil Cellular Immunotherapy Market Forecast, 2021-2031
13.8.1 Fastest Growing Economy in Latin America
13.8.2 High Potential Manufacturing Environment
13.9 Mexico Cellular Immunotherapy Market Forecast, 2021-2031
13.9.1 Lower Manufacturing Costs than In the US
13.9.2 Strategic Initiatives Undertaken By Market Players
13.10 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031
13.10.1 Evolving Healthcare Infrastructure in Latin America
14 MEA Cellular Immunotherapy Market, 2021-2031
14.1 Rising Prevalence of Cancer in MEA Region
14.2 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.3 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.4 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.5 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.6 MEA Cellular Immunotherapy Market Forecast by Indication
14.7 Recovery Scenarios (V, U, W, L): MEA Market
14.7.1 V-Shaped Recovery
14.7.1.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.1.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.1.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.1.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.1.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.2 U-Shaped Recovery
14.7.2.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.2.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.2.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.2.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.2.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.3 W-Shaped Recovery
14.7.3.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.3.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.3.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.3.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.3.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.4 L-Shaped Recovery
14.7.4.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.4.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.4.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.4.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.4.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.8 South Africa Cellular Immunotherapy Market Forecast, 2021-2031
14.8.1 Prevalence of Cancer in South Africa is Increasing Rapidly
14.8.2 Population Exposed to Mining Suffers from Cancer
14.9 GCC Cellular Immunotherapy Market Forecast, 2021-2031
14.9.1 Presence of Huge Growth Opportunities
14.9.2 Advances in personalised medicine and immuno-oncology have ushered in a paradigm change
14.10 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031
14.10.1 Cancer Is One of the Leading Causes of Death
14.10.2 Extensive Tobacco Use Increases Incidence of Cancer
15 Company Profiles: Cellular Immunotherapy Market
15.1 Cellular Immunotherapy Market: Company Share Analysis
15.2 Cellular Immunotherapy Market Recent Developments, 2017-2021
15.3 Novartis AG
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2016-2020
15.3.3.2 Business Segments Revenue Shares, 2020
15.3.3.3 Pharmaceuticals Business Unit Revenue Shares, 2020
15.3.3.4 Regional Revenue Shares, 2020
15.3.4 Product Benchmarking
15.3.5 Recent Developments, 2017-2021
15.4 Gilead Sciences, Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2016-2020
15.4.3.2 Business Segments Revenue Shares, 2020
15.4.3.3 Regional Revenue Shares, 2020
15.4.4 Product Benchmarking
15.4.5 Recent Developments, 2017-2021
15.5 Adicet Bio
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2016-2020
15.5.4 Product Benchmarking
15.5.5 Recent Developments, 2018-2021
15.6 GlaxoSmithKline plc.
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Revenue, 2016-2020
15.6.3.2 Pharmaceutical Business Revenue Share, 2020
15.6.3.3 Regional Revenue Shares, 2020
15.6.4 Product Benchmarking
15.6.5 Recent Developments, 2018-2021
15.7 Pfizer Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2016-2020
15.7.3.2 Product Revenue Shares, 2020
15.7.3.3 Regional Revenue Shares, 2020
15.7.4 Product Benchmarking
15.7.5 Recent Developments, 2018-2021
15.8 F. Hoffmann-La Roche Ltd.
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2016-2020
15.8.3.2 Product Revenue Shares, 2020
15.8.3.3 Regional Revenue Shares, 2020
15.8.4 Product Benchmarking
15.8.5 Recent Developments, 2018-2021
15.9 Iovance Biotherapeutics, Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments, 2018-2021
15.10 Tessa Therapeutics Ltd.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments, 2018-2021
15.11 Inovio Pharmaceuticals, Inc.
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2016-2020
15.11.4 Product Benchmarking
15.11.5 Recent Developments, 2018-2021
15.12 AstraZeneca
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2016-2020
15.12.3.2 Product Revenue Shares, 2020
15.12.3.3 Regional Revenue Shares, 2020
15.12.4 Product Benchmarking
15.12.5 Recent Developments, 2018-2021
15.13 Adaptimmune Therapeutics plc.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2016-2020
15.13.4 Product Benchmarking
15.14 Atara Biotherapeutics, Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Product Benchmarking
15.14.4 Recent Developments, 2018-2021
15.15 Bristol-Myers Squibb Company
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2016-2020
15.15.3.2 Regional Revenue Shares, 2020
15.15.4 Product Benchmarking
15.15.5 Recent Developments, 2018-2021
15.16 APAC Biotech
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.17 JW shinyak (JW CreaGene)
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Product Benchmarking
15.17.4 Recent Developments, 2018-2021
16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players
16.3 Leading Regions and Fastest Growing Region (North America Region Accounted
List of Tables
Table 1 Global Cellular Immunotherapy Market, 2020 & 2031 (US$ bn, CAGR %)
Table 2 Worldwide Cancer Incidence, 2020
Table 3 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031
Table 4 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "V" Shaped Recovery
Table 5 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "U" Shaped Recovery
Table 6 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "W" Shaped Recovery
Table 7 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "L" Shaped Recovery
Table 8 Global Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 9 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 14 Global NK Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 15 “V” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 16 “U” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 17 “W” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 18 “L” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 19 Global TIL Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 20 “V” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 21 “U” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 22 “W” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 23 “L” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 24 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 25 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 26 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 27 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 28 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 29 Global Cellular Immunotherapy Market Forecast by Product and Services, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 30 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 31 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 36 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 41 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 42 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 43 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 44 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 45 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 46 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 47 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 48 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 49 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 50 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 51 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 52 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 53 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 54 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 55 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 56 Global Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 57 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 58 “V” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 59 “U” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 60 “W” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 61 “L” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 62 Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 63 “V” Shaped Recovery: Global B-cell malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 64 “U” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 65 “W” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 66 “L” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 67 Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 68 “V” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 72 Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 77 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 82 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 83 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 84 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 85 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 86 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 87 North America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 88 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 89 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 90 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 91 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 92 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 93 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 94 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 95 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 96 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 97 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 98 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 99 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 100 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 101 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 102 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 103 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 104 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 105 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 106 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 107 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 108 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 109 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 110 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 111 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 112 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 113 U.S. Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 114 Canada Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 115 Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 116 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 117 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 118 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 119 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 120 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 121 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 122 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 123 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 124 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 125 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 126 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 127 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 128 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 129 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 130 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 131 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 132 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 133 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 134 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 135 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 136 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 137 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 138 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 139 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 140 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 141 Germany Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 142 UK Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 143 France Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 144 Italy Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 145 Spain Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 146 Russia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 147 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 148 Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 149 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 150 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 151 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 152 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 154 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 155 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 156 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 157 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 158 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 159 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 160 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 161 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 162 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 163 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 164 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 165 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 166 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 167 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 168 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 169 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 170 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 171 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 172 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 173 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 174 Japan Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 175 China Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 176 India Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 177 Australia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 178 South Korea Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 179 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 180 Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 181 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 182 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 183 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 184 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 185 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 186 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 187 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 188 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 189 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 190 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 191 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 192 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 193 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 194 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 195 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 196 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 197 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 198 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 199 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 200 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 201 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 202 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 203 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 204 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 205 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 206 Brazil Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 207 Mexico Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 208 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 209 MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 210 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 211 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 212 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 213 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 214 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 215 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 216 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 217 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 218 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 219 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 220 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 221 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 222 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 223 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 224 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 225 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 226 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 227 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 228 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 229 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 230 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 231 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 232 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 233 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 234 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 235 South Africa Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 236 GCC Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 237 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 238 Cellular Immunotherapy Market Recent Developments, 2018-2021
Table 239 Novartis AG: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 240 Novartis AG: Product Benchmarking
Table 241 Novartis AG : Recent Developments, 2018-2021
Table 242 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 1 Kite Corporate (Gilead Sciences, Inc.): Product Benchmarking
Table 243 Kite Corporate (Gilead Sciences, Inc.) : Recent Developments, 2018-2021
Table 244 Adicet Bio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Adicet Bio: Product Benchmarking
Table 246 Adicet Bio : Recent Developments, 2018-2021
Table 247 GlaxoSmithKline plc.: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 248 GlaxoSmithKline plc: Product Benchmarking
Table 249 GlaxoSmithKline plc: Recent Developments, 2018-2021
Table 250 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 251 Pfizer Inc.: Product Benchmarking
Table 252 Pfizer Inc. : Recent Developments, 2018-2021
Table 253 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 254 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 255 F. Hoffmann-La Roche Ltd.: Recent Developments, 2018-2021
Table 256 Iovance Biotherapeutics, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website)
Table 257 Iovance Biotherapeutics, Inc.: Product Benchmarking
Table 258 Iovance Biotherapeutics, Inc. : Recent Developments, 2018-2021
Table 259 Tessa Therapeutics Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 260 Tessa Therapeutics Ltd.: Product Benchmarking
Table 261 Tessa Therapeutics Ltd. : Recent Developments, 2018-2021
Table 262 Inovio Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Inovio Pharmaceuticals, Inc.: Product Benchmarking
Table 264 Inovio Pharmaceuticals, Inc.: Recent Developments, 2018-2021
Table 265 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 AstraZeneca: Product Benchmarking
Table 267 AstraZeneca : Recent Developments, 2018-2021
Table 268 Adaptimmune Therapeutics plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 Adaptimmune Therapeutics plc.: Product Benchmarking
Table 270 Atara Biotherapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Atara Biotherapeutics, Inc.: Product Benchmarking
Table 272 Atara Biotherapeutics, Inc.: Recent Developments, 2018-2021
Table 273 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Bristol-Myers Squibb Company: Product Benchmarking
Table 275 Bristol-Myers Squibb Company: Recent Developments, 2018-2021
Table 276 APAC Biotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 APAC Biotech: Product Benchmarking
Table 278 JW shinyak (JW CreaGene): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 279 JW shinyak (JW CreaGene): Product Benchmarking
Table 280 JW shinyak (JW CreaGene): Recent Developments, 2018-2021
List of Figures
Figure 1 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %)
Figure 2 Global Cellular Immunotherapy Market Segmentation
Figure 3 Global Cellular Immunotherapy Market: Market Trends
Figure 4 Global Cellular Immunotherapy Market: SWOT Analysis
Figure 5 Global Cellular Immunotherapy Market: Porter’s Five Forces Analysis
Figure 6 Global Cellular Immunotherapy Market: PEST Analysis
Figure 7 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %)
Figure 8 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "V" Shaped Recovery
Figure 9 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "U" Shaped Recovery
Figure 10 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "W" Shaped Recovery
Figure 11 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "L" Shaped Recovery
Figure 12 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 13 “V” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 14 “U” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 15 “W” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 16 “L” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 17 Global NK Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 18 “V” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 19 “U” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 20 “W” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 21 “L” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 22 Global TIL Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 23 “V” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 “U” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 25 “W” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 26 “L” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 27 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 28 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 30 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 31 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 32 Global Cellular Immunotherapy Market Share Forecast by Product and Services, 2021, 2026, 2031 (%)
Figure 33 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 34 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 35 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 36 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 37 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 38 Global Cellular Immunotherapy Market for Services Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 39 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 40 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 41 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 42 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 43 Global Cellular Immunotherapy Market Share Forecast by Testing Assays Type, 2021, 2026, 2031 (%)
Figure 44 Global Cellular Immunotherapy Market for Bioanalytics Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 45 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 46 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 47 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 48 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 49 Global Cellular Immunotherapy Market for Characterization Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 50 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 51 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 52 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 53 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 54 Global Cellular Immunotherapy Market for Biosafety Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 55 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 56 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 57 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 58 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 59 Global Cellular Immunotherapy Market Share Forecast by Indication, 2021, 2026, 2031 (%)
Figure 60 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 61 “V” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 62 “U” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 63 “W” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 64 “L” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 65 Global Prostate Cancer Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 66 “V” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 67 “U” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 68 “W” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 69 “L” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 70 Global Liver Cancer Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 71 “V” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 72 “U” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 73 “W” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 74 “L” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 75 Global Renal Cell Carcinoma Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 76 “V” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 77 “U” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 78 “W” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 79 “L” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 80 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 81 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 82 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 83 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 84 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 85 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion): “V” Shaped Recovery
Figure 86 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion): “U” Shaped Recovery
Figure 87 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 88 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 89 North America Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 90 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 91 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 92 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 93 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 94 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 95 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 96 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 97 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 98 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 99 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 100 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 101 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 102 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 103 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 104 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 105 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 106 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 107 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 108 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 109 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 110 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 111 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 112 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 113 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 114 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 115 U.S. Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 116 Canada Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 117 Europe Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 118 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 119 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 120 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 121 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 122 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 123 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 124 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 125 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 126 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 127 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 128 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 129 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 130 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 131 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 132 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 133 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 134 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 135 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 136 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 137 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 138 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 139 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 140 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 141 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 142 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 143 Germany Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 144 UK Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 145 France Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 146 Italy Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 147 Spain Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 148 Russia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 149 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 150 Asia Pacific Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 151 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 152 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 153 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 154 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 155 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 156 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 157 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 158 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 159 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 160 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 161 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 162 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 163 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 164 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 165 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 166 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 167 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 168 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 169 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 170 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 171 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 172 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 173 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 174 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 175 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 176 Japan Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 177 China Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 178 India Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 179 Australia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 180 South Korea Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 181 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 182 Latin America Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 183 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 184 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 185 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 186 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 187 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 188 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 189 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 190 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 191 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 192 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 193 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 194 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 195 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 196 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 197 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 198 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 199 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 200 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 201 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 202 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 203 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 204 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 205 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 206 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 207 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 208 Brazil Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 209 Mexico Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 210 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 211 MEA Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 212 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 213 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 214 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 215 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 216 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 217 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 218 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 219 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 220 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 221 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 222 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 223 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 224 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 225 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 226 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 227 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 228 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 229 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 230 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 231 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 232 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 233 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 234 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 235 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 236 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 237 South Africa Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 238 GCC Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 239 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 240 Cellular Immunotherapy Market: Company Share Analysis, 2020
Figure 241 Novartis AG: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 242 Novartis AG: Business Segments Revenue Shares, 2020
Figure 243 Novartis AG: Pharmaceuticals Business Unit Revenue Shares, 2020
Figure 244 Novartis AG: Regional Revenue Shares, 2020
Figure 245 Gilead Sciences, Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 246 Gilead Sciences, Inc.: Business Segments Revenue Shares, 2020
Figure 247 Gilead Sciences, Inc.: Regional Revenue Shares, 2020
Figure 248 Adicet Bio: Net Revenue, 2016-2020 (US$ Million, AGR%)
Figure 249 GlaxoSmithKline plc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 250 GlaxoSmithKline plc.: Pharmaceutical Business Revenue Shares, 2020
Figure 251 GlaxoSmithKline plc.: Regional Revenue Shares, 2020
Figure 252 Pfizer Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 253 Pfizer Inc.: Product Segment Revenue Shares, 2020
Figure 254 Pfizer Inc.: Regional Segment Revenue Shares, 2020
Figure 255 F. Hoffmann-La Roche Ltd.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 256 F. Hoffmann-La Roche Ltd.: Product Revenue Shares, 2020
Figure 257 F. Hoffmann-La Roche Ltd.: Regional Revenue Shares, 2020
Figure 258 Inovio Pharmaceuticals, Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 259 AstraZeneca: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 260 AstraZeneca: Product Revenue Shares, 2020
Figure 261 AstraZeneca: Regional Revenue Shares, 2020
Figure 262 Adaptimmune Therapeutics plc.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 263 Bristol-Myers Squibb Company: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 264 Bristol-Myers Squibb Company: Regional Revenue Shares, 2020
Figure 265 Global Cellular Immunotherapy Market Share Forecast by Therapy Type, 2021, 2026, 2031 (%)
Figure 266 Global Cellular Immunotherapy Market Share Forecast by Region, 2021, 2026, 2031 (%)
1.1 Introduction to Cellular Immunotherapy Market
1.2 Why You Should Read This Report
1.3 What This Report Delivers
1.4 Key Questions Answered By This Analytical Report Include:
1.5 Who is This Report For?
1.6 Methodology
1.6.1 Primary Research
1.6.2 Secondary Research
1.6.3 Market Evaluation & Forecast Methodology
1.7 Frequently Asked Questions (FAQs)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2 Executive Summary
3 Market Dynamics
3.1 Drivers for Cellular Immunotherapy Market
3.1.1 Increasing Prevalence of Cancer is driving the Market
3.1.2 Increasing Geriatric Population around the World is Boosting the Demand for Cellular Immunotherapy
3.1.3 Development of Advanced Cellular Immunotherapy is Driving the Cellular Immunotherapy Market
3.1.4 Support from National Cancer Institute for Immunotherapy is estimated to propel the Market Growth
3.2 Restraints for Cellular Immunotherapy Market
3.2.1 Stringent Regulations Associated with Product Development Hinders the Market Growth
3.2.2 High Costs of Cellular Immunotherapy Limits the Market Growth
3.2.3 Complex Supply Chain and Manufacturing Could limit the Entry of New Players
3.3 Opportunities for Cellular Immunotherapy Market
3.3.1 Increasing Demand for the Advanced Cellular Immunotherapy for Cancer Treatment Is Projected to Boost the Market Growth
3.3.2 Mergers, Agreements, and Acquisitions by the Market Players is a Major Trend Witnessed in the Market
3.4 Challenges for Cellular Immunotherapy Market
3.4.1 Adverse Effects associated With Cellular Immunotherapy could Limit its Adoption
3.4.2 Reimbursement Issues for the Advanced Cellular Immunotherapy
3.5 SWOT Analysis for Cellular Immunotherapy Market
3.5.1 Strengths: Cellular Immunotherapy Market
3.5.1.1 Rising Popularity of Cellular Immunotherapy for Cancer Treatment
3.5.1.2 Escalating Clinical-research Infrastructure in Asia Pacific Region
3.5.2 Weaknesses: Cellular Immunotherapy Market
3.5.2.1 Complexity of Cellular Immunotherapies
3.5.2.2 Changing Regulatory Requirements
3.5.3 Opportunities: Cellular Immunotherapy Market
3.5.3.1 Increase in Collaborations between Biopharmaceutical Companies and Academic Research Centers
3.5.3.2 Advantages of CAR-T-Therapy for the Treatment of Liquid Tumors
3.5.4 Threats: Cellular Immunotherapy Market
3.5.4.1 Availability of Alternative Treatment Options
3.5.4.2 Ethical Issues Associated with Cellular Immunotherapy
3.6 Porter’s Five Forces Analysis: Cellular Immunotherapy Market
3.6.1 Bargaining Power of Supplier: High
3.6.2 Bargaining Power of Buyer: Low
3.6.3 Competitive Rivalry: High
3.6.4 Threat of New Entrants: Moderate
3.6.5 Threat of Substitutes: Low
3.7 PEST Analysis: Cellular Immunotherapy Market
3.7.1 Political Factors Impacting Cellular Immunotherapy Market
3.7.2 Economic Factors Impacting Cellular Immunotherapy Market
3.7.3 Social Factors Impacting Cellular Immunotherapy Market
3.7.4 Technological Factors Impacting Cellular Immunotherapy Market
4 COVID-19 Impact: Global Cellular Immunotherapy Market
4.1 Global Cellular Immunotherapy Market Forecast, 2021-2031
4.2 COVID-19 Impact Overview
4.3 "V" shaped Recovery - Rapid Decline - Sharp Borrow -Rapid Recovery
4.4 "U" Shaped Recovery -Rapid Decline Early Then Slow - Gradual at the Bottom - Slow Recovery at First - Faster Recovery Later On
4.5 "W" Shaped Recovery -Rapid Decline - Rapid Recovery- Return of Virus - Another Sharp Decline -Recovery
4.6 "L" Shaped Recovery - Rapid Decline - Then Slow Growth
5 Global Cellular Immunotherapy Market Size Forecast 2021-2031 by Therapy Type
5.1 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031
5.1.1 CAR-T Cell Therapy is the Largest Revenue Grossing Segment
5.1.2 Recovery Forecasts (V, U, W, L)
5.2 Global NK (Natural Killer) Cell Therapy Segment: Revenue Forecast 2021-2031
5.2.1 NK Cell Lines Offer a Robust Cytotoxicity against Cancer Cells
5.2.2 Recovery Forecasts (V, U, W, L)
5.3 Global Tumor-Infiltrating Lymphocyte (TIL) Therapy Segment: Revenue Forecast 2021-2031
5.3.1 TIL Therapy is a Promising form of Adoptive Cellular Immunotherapy
5.3.2 Recovery Forecasts (V, U, W, L)
5.4 Global Others Segment: Revenue Forecast 2021-2031
5.4.1 Promising Engineered T-Cell Receptor (TCR) and Dendritic Cell (DC)-based Therapies are expected to boost the Other Cell Therapy Segment Growth
5.4.2 Recovery Forecasts (V, U, W, L)
6 Cellular Immunotherapy Market by Product and Services Forecast, 2021-2031
6.1 Global Cellular Immunotherapy Product Segment Market Forecast, 2021-2031
6.1.1 Cellular Immunotherapy Product Segment is showing the Highest CAGR during the Forecast Period
6.1.2 Recovery Scenarios (V, U, W, L)
6.2 Global Cellular Immunotherapy Services Segment Market Forecast, 2021-2031
6.2.1 Rising Investment in Cell-Based Therapies R&D is driving the Cellular Immunotherapy Services Segment
6.2.2 Recovery Scenarios (V, U, W, L)
7 Cellular Immunotherapy Market by Testing Assays Type Forecast, 2021-2031
7.1 Bioanalytics Segment Market Forecast, 2021-2031
7.1.1 Largest-Revenue Growing Segment in the Market
7.1.2 Recovery Scenarios (V, U, W, L)
7.2 Characterization Segment Market Forecast, 2021-2031
7.2.1 Second-Largest Revenue Generating Segment
7.2.2 Recovery Scenarios (V, U, W, L)
7.3 Biosafety Segment Market Forecast, 2021-2031
7.3.1 Well-defined Regulations for the Cellular Therapies in the Developed Countries Is Expected To Drive the Market Growth
7.3.2 Recovery Scenarios (V, U, W, L)
8 Global Cellular Immunotherapy Market Size Forecast 2021-2031 by Indication
8.1 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031
8.1.1 B-cell Malignancies is the Largest Revenue Grossing Segment
8.1.2 Recovery Forecasts (V, U, W, L)
8.2 Global Prostate Cancer Segment: Revenue Forecast 2021-2031
8.2.1 sipuleucel-T (Provenge) has been Approved by the US FDA for the Treatment of Prostate Cancer
8.2.2 Recovery Forecasts (V, U, W, L)
8.3 Global Liver Cancer Segment: Revenue Forecast 2021-2031
8.3.1 Liver Cancer Segment is Expected to Grow at a Lucrative Growth Rate
8.3.2 Recovery Forecasts (V, U, W, L)
8.4 Global Renal Cell Carcinoma Segment: Revenue Forecast 2021-2031
8.4.1 Growing Investment in Cellular Immunotherapy for the Treatment of Renal Cell Carcinoma is projected to Drive the Segment Growth
8.4.2 Recovery Forecasts (V, U, W, L)
8.5 Global Others Segment: Revenue Forecast 2021-2031
8.5.1 Growing Demand for Advanced Drugs Is Expected to Propel the Others Segment Growth
8.5.2 Recovery Forecasts (V, U, W, L)
9 National Cellular Immunotherapy Market Forecast, 2021-2031
9.1 Global Cellular Immunotherapy Market by Region Forecast 2021-2031
9.1 Recovery Scenarios (V, U, W, L)
10 North America Cellular Immunotherapy Market, 2021-2031
10.1 North America is the Largest Revenue Grossing Region in the Global Market
10.2 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.3 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.4 North America Cellular Immunotherapy Market Forecast by Product & Service
10.5 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.6 North America Cellular Immunotherapy Market Forecast by Indication
10.7 Recovery Scenarios (V, U, W, L): North America Market
10.7.1 V-Shaped Recovery
10.7.1.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.1.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.1.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.1.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.1.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.2 U-Shaped Recovery
10.7.2.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.2.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.2.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.2.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.2.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.3 W-Shaped Recovery
10.7.3.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.3.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.3.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.3.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.3.5 North America Cellular Immunotherapy Market Forecast by Indication
10.7.4 L-Shaped Recovery
10.7.4.1 North America Cellular Immunotherapy Market by Country, Forecast 2021-2031
10.7.4.2 North America Cellular Immunotherapy Market Forecast by Therapy Type
10.7.4.3 North America Cellular Immunotherapy Market Forecast by Product & Service
10.7.4.4 North America Cellular Immunotherapy Market Forecast by Testing Assays Type
10.7.4.5 North America Cellular Immunotherapy Market Forecast by Indication
10.8 U.S. Cellular Immunotherapy Market Forecast, 2021-2031
10.8.1 Presence of Leading Players is a Major factor driving the U.S. Cellular Imunotherapy Market
10.8.2 Presence of Highly Developed Healthcare Infrastructure
10.9 Canada Cellular Immunotherapy Market Forecast, 2021-2031
10.9.1 Canada Market Anticipated To Witness the Fastest Growth in the North America Region
10.9.2 Growing Canadian research collaborations determined to Provide Infrastructure for Cell-Based Therapy Research
11 Europe Cellular Immunotherapy Market, 2021-2031
11.1 Second Largest Market in the Global Market
11.2 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.3 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.4 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.5 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.6 Europe Cellular Immunotherapy Market Forecast by Indication
11.7 Recovery Scenarios (V, U, W, L): Europe Market
11.7.1 V-Shaped Recovery
11.7.1.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.1.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.1.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.1.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.1.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.2 U-Shaped Recovery
11.7.2.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.2.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.2.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.2.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.2.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.3 W-Shaped Recovery
11.7.3.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.3.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.3.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.3.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.3.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.7.4 L-Shaped Recovery
11.7.4.1 Europe Cellular Immunotherapy Market by Country, Forecast 2021-2031
11.7.4.2 Europe Cellular Immunotherapy Market Forecast by Therapy Type
11.7.4.3 Europe Cellular Immunotherapy Market Forecast by Product & Service
11.7.4.4 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type
11.7.4.5 Europe Cellular Immunotherapy Market Forecast by Indication
11.8 Germany Cellular Immunotherapy Market Forecast, 2021-2031
11.8.1 Growing Geriatric Population In This Region Is Expected To Boost The Regional Market Growth
11.8.2 Rising Focus on CAR-T Cell and NK Cell Therapies R&D in Germany
11.9 UK Cellular Immunotherapy Market Forecast, 2021-2031
11.9.1 Presence of Well-Developed R&D Infrastructure
11.9.2 Rise in Number of Treatment Centers in the UK
11.10 France Cellular Immunotherapy Market Forecast, 2021-2031
11.10.1 Growing Demand for Advanced Healthcare Services
11.10.2 Rising Preference for France for Cellular Therapy R&D and Manufacturing by Leading Players
11.11 Italy Cellular Immunotherapy Market Forecast, 2021-2031
11.11.1 Pharmaceutical Manufacturing Hub
11.11.2 Growing Acceptance of Cellular Therapies for the Treatment of Cancer in Italy is projected to drive the Market Growth
11.12 Spain Cellular Immunotherapy Market Forecast, 2021-2031
11.12.1 Demand for Drugs Is Influenced By the Growth of the Pharmaceutical Industry
11.12.2 Spanish Economy Is Growing Strong
11.13 Russia Cellular Immunotherapy Market Forecast, 2021-2031
11.13.1 Growing Government Support for the Development of Advanced Cancer Therapies
11.13.2 Unmet Pharmaceutical Needs
11.14 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031
11.14.1 Increasing Prevalence of Cancer
12 Asia Pacific Cellular Immunotherapy Market, 2021-2031
12.1 Asia Pacific is the Fastest Growing Market
12.2 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.3 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.4 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.5 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.6 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7 Recovery Scenarios (V, U, W, L): APAC Market
12.7.1 V-Shaped Recovery
12.7.1.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.1.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.1.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.1.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.1.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.2 U-Shaped Recovery
12.7.2.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.2.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.2.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.2.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.2.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.3 W-Shaped Recovery
12.7.3.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.3.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.3.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.3.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.3.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.7.4 L-Shaped Recovery
12.7.4.1 Asia Pacific Cellular Immunotherapy Market by Country, Forecast 2021-2031
12.7.4.2 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type
12.7.4.3 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service
12.7.4.4 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type
12.7.4.5 Asia Pacific Cellular Immunotherapy Market Forecast by Indication
12.8 Japan Cellular Immunotherapy Market Forecast, 2021-2031
12.8.1 Japan Accounted For the Largest Market Share in the Asia Pacific Region
12.8.2 Rising Number of Product Approval is Expected to Drive the Market Growth
12.9 China Cellular Immunotherapy Market Forecast, 2021-2031
12.9.1 Strategic Initiatives Undertaken by the Market Players
12.9.2 Increasing Healthcare Spending In China
12.10 India Cellular Immunotherapy Market Forecast, 2021-2031
12.10.1 Developing Healthcare Infrastructure
12.10.2 Increasing Prevalence of Cancer
12.11 Australia Cellular Immunotherapy Market Forecast, 2021-2031
12.11.1 Government Programs to Expand Access to Quality Healthcare
12.11.2 Launch of Cell-based Therapies in Australia is Projected to Boost the Market Growth
12.12 South Korea Cellular Immunotherapy Market Forecast, 2021-2031
12.12.1 Growing Healthcare Awareness among People
12.12.2 Rising Cancer Incidence is Expected to Drive theSouth Korea Market
12.13 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031
12.13.1 Rising Disposable Income
13 Latin America Cellular Immunotherapy Market, 2021-2031
13.1 Latin America Cellular Immunotherapy Market
13.2 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.3 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.4 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.5 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.6 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7 Recovery Scenarios (V, U, W, L): Latin America Market
13.7.1 V-Shaped Recovery
13.7.1.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.1.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.1.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.1.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.1.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.2 U-Shaped Recovery
13.7.2.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.2.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.2.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.2.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.2.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.3 W-Shaped Recovery
13.7.3.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.3.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.3.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.3.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.3.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.7.4 L-Shaped Recovery
13.7.4.1 Latin America Cellular Immunotherapy Market by Country, Forecast 2021-2031
13.7.4.2 Latin America Cellular Immunotherapy Market Forecast by Therapy Type
13.7.4.3 Latin America Cellular Immunotherapy Market Forecast by Product & Service
13.7.4.4 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type
13.7.4.5 Latin America Cellular Immunotherapy Market Forecast by Indication
13.8 Brazil Cellular Immunotherapy Market Forecast, 2021-2031
13.8.1 Fastest Growing Economy in Latin America
13.8.2 High Potential Manufacturing Environment
13.9 Mexico Cellular Immunotherapy Market Forecast, 2021-2031
13.9.1 Lower Manufacturing Costs than In the US
13.9.2 Strategic Initiatives Undertaken By Market Players
13.10 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031
13.10.1 Evolving Healthcare Infrastructure in Latin America
14 MEA Cellular Immunotherapy Market, 2021-2031
14.1 Rising Prevalence of Cancer in MEA Region
14.2 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.3 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.4 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.5 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.6 MEA Cellular Immunotherapy Market Forecast by Indication
14.7 Recovery Scenarios (V, U, W, L): MEA Market
14.7.1 V-Shaped Recovery
14.7.1.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.1.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.1.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.1.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.1.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.2 U-Shaped Recovery
14.7.2.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.2.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.2.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.2.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.2.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.3 W-Shaped Recovery
14.7.3.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.3.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.3.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.3.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.3.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.7.4 L-Shaped Recovery
14.7.4.1 MEA Cellular Immunotherapy Market by Country, Forecast 2021-2031
14.7.4.2 MEA Cellular Immunotherapy Market Forecast by Therapy Type
14.7.4.3 MEA Cellular Immunotherapy Market Forecast by Product & Service
14.7.4.4 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type
14.7.4.5 MEA Cellular Immunotherapy Market Forecast by Indication
14.8 South Africa Cellular Immunotherapy Market Forecast, 2021-2031
14.8.1 Prevalence of Cancer in South Africa is Increasing Rapidly
14.8.2 Population Exposed to Mining Suffers from Cancer
14.9 GCC Cellular Immunotherapy Market Forecast, 2021-2031
14.9.1 Presence of Huge Growth Opportunities
14.9.2 Advances in personalised medicine and immuno-oncology have ushered in a paradigm change
14.10 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031
14.10.1 Cancer Is One of the Leading Causes of Death
14.10.2 Extensive Tobacco Use Increases Incidence of Cancer
15 Company Profiles: Cellular Immunotherapy Market
15.1 Cellular Immunotherapy Market: Company Share Analysis
15.2 Cellular Immunotherapy Market Recent Developments, 2017-2021
15.3 Novartis AG
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.3.1 Net Revenue, 2016-2020
15.3.3.2 Business Segments Revenue Shares, 2020
15.3.3.3 Pharmaceuticals Business Unit Revenue Shares, 2020
15.3.3.4 Regional Revenue Shares, 2020
15.3.4 Product Benchmarking
15.3.5 Recent Developments, 2017-2021
15.4 Gilead Sciences, Inc.
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.3.1 Net Revenue, 2016-2020
15.4.3.2 Business Segments Revenue Shares, 2020
15.4.3.3 Regional Revenue Shares, 2020
15.4.4 Product Benchmarking
15.4.5 Recent Developments, 2017-2021
15.5 Adicet Bio
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2016-2020
15.5.4 Product Benchmarking
15.5.5 Recent Developments, 2018-2021
15.6 GlaxoSmithKline plc.
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Revenue, 2016-2020
15.6.3.2 Pharmaceutical Business Revenue Share, 2020
15.6.3.3 Regional Revenue Shares, 2020
15.6.4 Product Benchmarking
15.6.5 Recent Developments, 2018-2021
15.7 Pfizer Inc.
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2016-2020
15.7.3.2 Product Revenue Shares, 2020
15.7.3.3 Regional Revenue Shares, 2020
15.7.4 Product Benchmarking
15.7.5 Recent Developments, 2018-2021
15.8 F. Hoffmann-La Roche Ltd.
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.3.1 Net Revenue, 2016-2020
15.8.3.2 Product Revenue Shares, 2020
15.8.3.3 Regional Revenue Shares, 2020
15.8.4 Product Benchmarking
15.8.5 Recent Developments, 2018-2021
15.9 Iovance Biotherapeutics, Inc.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.9.4 Recent Developments, 2018-2021
15.10 Tessa Therapeutics Ltd.
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Product Benchmarking
15.10.4 Recent Developments, 2018-2021
15.11 Inovio Pharmaceuticals, Inc.
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2016-2020
15.11.4 Product Benchmarking
15.11.5 Recent Developments, 2018-2021
15.12 AstraZeneca
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2016-2020
15.12.3.2 Product Revenue Shares, 2020
15.12.3.3 Regional Revenue Shares, 2020
15.12.4 Product Benchmarking
15.12.5 Recent Developments, 2018-2021
15.13 Adaptimmune Therapeutics plc.
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Financial Analysis
15.13.3.1 Net Revenue, 2016-2020
15.13.4 Product Benchmarking
15.14 Atara Biotherapeutics, Inc.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Product Benchmarking
15.14.4 Recent Developments, 2018-2021
15.15 Bristol-Myers Squibb Company
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Financial Analysis
15.15.3.1 Net Revenue, 2016-2020
15.15.3.2 Regional Revenue Shares, 2020
15.15.4 Product Benchmarking
15.15.5 Recent Developments, 2018-2021
15.16 APAC Biotech
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Product Benchmarking
15.17 JW shinyak (JW CreaGene)
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Product Benchmarking
15.17.4 Recent Developments, 2018-2021
16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players
16.3 Leading Regions and Fastest Growing Region (North America Region Accounted
List of Tables
Table 1 Global Cellular Immunotherapy Market, 2020 & 2031 (US$ bn, CAGR %)
Table 2 Worldwide Cancer Incidence, 2020
Table 3 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031
Table 4 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "V" Shaped Recovery
Table 5 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "U" Shaped Recovery
Table 6 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "W" Shaped Recovery
Table 7 Global Cellular Immunotherapy Market Size Forecast: Revenue ($bn), AGR (%), CAGR (%), 2021-2031: "L" Shaped Recovery
Table 8 Global Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 9 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 10 “V” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 11 “U” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 12 “W” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 13 “L” Shaped Recovery: Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 14 Global NK Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 15 “V” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 16 “U” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 17 “W” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 18 “L” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 19 Global TIL Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 20 “V” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 21 “U” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 22 “W” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 23 “L” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 24 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 25 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 26 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 27 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 28 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 29 Global Cellular Immunotherapy Market Forecast by Product and Services, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 30 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 31 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 32 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 33 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 34 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 35 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 36 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 37 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 38 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 39 Global Cellular Immunotherapy Market for Services Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 40 Global Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 41 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 42 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 43 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 44 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 45 Global Cellular Immunotherapy Market for Bioanalytics Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 46 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 47 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 48 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 49 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 50 Global Cellular Immunotherapy Market for Characterization Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 51 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 52 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 53 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 54 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 55 Global Cellular Immunotherapy Market for Biosafety Segment Forecast, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 56 Global Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 57 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 58 “V” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 59 “U” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 60 “W” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 61 “L” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 62 Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 63 “V” Shaped Recovery: Global B-cell malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 64 “U” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 65 “W” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 66 “L” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 67 Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR %)
Table 68 “V” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 69 “U” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 70 “W” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 71 “L” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 72 Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 73 “V” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 74 “U” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 75 “W” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 76 “L” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 77 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 78 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 79 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 80 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 81 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%, CAGR%)
Table 82 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 83 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "V" Shaped Recovery
Table 84 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "U" Shaped Recovery
Table 85 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "W" Shaped Recovery
Table 86 Global Cellular Immunotherapy Market Forecast by Region, 2021-2031 (US$ bn, AGR%, CAGR%): "L" Shaped Recovery
Table 87 North America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 88 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 89 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 90 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 91 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 92 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 93 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 94 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 95 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 96 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 97 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 98 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 99 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 100 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 101 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 102 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 103 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 104 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 105 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 106 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 107 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 108 North America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 109 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 110 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 111 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 112 North America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 113 U.S. Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 114 Canada Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 115 Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 116 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 117 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 118 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 119 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 120 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 121 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 122 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 123 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 124 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 125 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 126 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 127 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 128 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 129 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 130 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 131 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 132 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 133 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 134 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 135 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 136 Europe Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 137 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 138 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 139 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 140 Europe Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 141 Germany Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR %)
Table 142 UK Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 143 France Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 144 Italy Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 145 Spain Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 146 Russia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 147 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 148 Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 149 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 150 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 151 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 152 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 153 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 154 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 155 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 156 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 157 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 158 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 159 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 160 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 161 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 162 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 163 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 164 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 165 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 166 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 167 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 168 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 169 Asia Pacific Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 170 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 171 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 172 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 173 Asia Pacific Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 174 Japan Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 175 China Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 176 India Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 177 Australia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 178 South Korea Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 179 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 180 Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 181 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 182 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 183 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 184 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 185 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 186 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 187 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 188 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 189 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 190 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 191 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 192 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 193 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 194 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 195 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 196 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 197 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 198 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 199 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 200 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 201 Latin America Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 202 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 203 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 204 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 205 Latin America Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 206 Brazil Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 207 Mexico Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 208 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 209 MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 210 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 211 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 212 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 213 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 214 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 215 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 216 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 217 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 218 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 219 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 220 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 221 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 222 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 223 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 224 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 225 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 226 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 227 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 228 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 229 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 230 MEA Cellular Immunotherapy Market Forecast by Country, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 231 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 232 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 233 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 234 MEA Cellular Immunotherapy Market Size Forecast by Indication, 2021-2031 (US$ billion, AGR %, CAGR %)
Table 235 South Africa Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 236 GCC Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 237 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ bn, AGR%, CAGR%)
Table 238 Cellular Immunotherapy Market Recent Developments, 2018-2021
Table 239 Novartis AG: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 240 Novartis AG: Product Benchmarking
Table 241 Novartis AG : Recent Developments, 2018-2021
Table 242 Gilead Sciences, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 1 Kite Corporate (Gilead Sciences, Inc.): Product Benchmarking
Table 243 Kite Corporate (Gilead Sciences, Inc.) : Recent Developments, 2018-2021
Table 244 Adicet Bio: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 245 Adicet Bio: Product Benchmarking
Table 246 Adicet Bio : Recent Developments, 2018-2021
Table 247 GlaxoSmithKline plc.: Key Details, (MD, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 248 GlaxoSmithKline plc: Product Benchmarking
Table 249 GlaxoSmithKline plc: Recent Developments, 2018-2021
Table 250 Pfizer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 251 Pfizer Inc.: Product Benchmarking
Table 252 Pfizer Inc. : Recent Developments, 2018-2021
Table 253 F. Hoffmann-La Roche Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 254 F. Hoffmann-La Roche Ltd.: Product Benchmarking
Table 255 F. Hoffmann-La Roche Ltd.: Recent Developments, 2018-2021
Table 256 Iovance Biotherapeutics, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website)
Table 257 Iovance Biotherapeutics, Inc.: Product Benchmarking
Table 258 Iovance Biotherapeutics, Inc. : Recent Developments, 2018-2021
Table 259 Tessa Therapeutics Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 260 Tessa Therapeutics Ltd.: Product Benchmarking
Table 261 Tessa Therapeutics Ltd. : Recent Developments, 2018-2021
Table 262 Inovio Pharmaceuticals, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 263 Inovio Pharmaceuticals, Inc.: Product Benchmarking
Table 264 Inovio Pharmaceuticals, Inc.: Recent Developments, 2018-2021
Table 265 AstraZeneca: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 266 AstraZeneca: Product Benchmarking
Table 267 AstraZeneca : Recent Developments, 2018-2021
Table 268 Adaptimmune Therapeutics plc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 269 Adaptimmune Therapeutics plc.: Product Benchmarking
Table 270 Atara Biotherapeutics, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 271 Atara Biotherapeutics, Inc.: Product Benchmarking
Table 272 Atara Biotherapeutics, Inc.: Recent Developments, 2018-2021
Table 273 Bristol-Myers Squibb Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 274 Bristol-Myers Squibb Company: Product Benchmarking
Table 275 Bristol-Myers Squibb Company: Recent Developments, 2018-2021
Table 276 APAC Biotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 277 APAC Biotech: Product Benchmarking
Table 278 JW shinyak (JW CreaGene): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 279 JW shinyak (JW CreaGene): Product Benchmarking
Table 280 JW shinyak (JW CreaGene): Recent Developments, 2018-2021
List of Figures
Figure 1 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %)
Figure 2 Global Cellular Immunotherapy Market Segmentation
Figure 3 Global Cellular Immunotherapy Market: Market Trends
Figure 4 Global Cellular Immunotherapy Market: SWOT Analysis
Figure 5 Global Cellular Immunotherapy Market: Porter’s Five Forces Analysis
Figure 6 Global Cellular Immunotherapy Market: PEST Analysis
Figure 7 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %)
Figure 8 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "V" Shaped Recovery
Figure 9 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "U" Shaped Recovery
Figure 10 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "W" Shaped Recovery
Figure 11 Global Cellular Immunotherapy Market Size Forecast 2021-2031 (US$bn, AGR %): "L" Shaped Recovery
Figure 12 Global CAR-T Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 13 “V” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 14 “U” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 15 “W” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 16 “L” Shaped Recovery: Global CAR-T Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 17 Global NK Cell Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 18 “V” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 19 “U” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 20 “W” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 21 “L” Shaped Recovery: Global NK Cell Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 22 Global TIL Therapy Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 23 “V” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 24 “U” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 25 “W” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 26 “L” Shaped Recovery: Global TIL Therapy Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 27 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 28 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 29 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 30 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 31 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 32 Global Cellular Immunotherapy Market Share Forecast by Product and Services, 2021, 2026, 2031 (%)
Figure 33 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 34 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 35 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 36 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 37 Global Cellular Immunotherapy Market for Cellular Immunotherapy Product Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 38 Global Cellular Immunotherapy Market for Services Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 39 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 40 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 41 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 42 Global Cellular Immunotherapy Market for Services Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 43 Global Cellular Immunotherapy Market Share Forecast by Testing Assays Type, 2021, 2026, 2031 (%)
Figure 44 Global Cellular Immunotherapy Market for Bioanalytics Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 45 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 46 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 47 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 48 Global Cellular Immunotherapy Market for Bioanalytics Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 49 Global Cellular Immunotherapy Market for Characterization Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 50 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 51 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 52 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 53 Global Cellular Immunotherapy Market for Characterization Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 54 Global Cellular Immunotherapy Market for Biosafety Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 55 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “V” Shaped Recovery
Figure 56 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “U” Shaped Recovery
Figure 57 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 58 Global Cellular Immunotherapy Market for Biosafety Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 59 Global Cellular Immunotherapy Market Share Forecast by Indication, 2021, 2026, 2031 (%)
Figure 60 Global B-cell Malignancies Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 61 “V” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 62 “U” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 63 “W” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 64 “L” Shaped Recovery: Global B-cell Malignancies Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 65 Global Prostate Cancer Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 66 “V” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 67 “U” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 68 “W” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 69 “L” Shaped Recovery: Global Prostate Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 70 Global Liver Cancer Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 71 “V” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 72 “U” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 73 “W” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 74 “L” Shaped Recovery: Global Liver Cancer Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 75 Global Renal Cell Carcinoma Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 76 “V” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 77 “U” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 78 “W” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 79 “L” Shaped Recovery: Global Renal Cell Carcinoma Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 80 Global Others Segment: Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 81 “V” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 82 “U” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 83 “W” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 84 “L” Shaped Recovery: Global Others Segment, Revenue Forecast 2021-2031 (US$ billion, AGR%)
Figure 85 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion): “V” Shaped Recovery
Figure 86 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion): “U” Shaped Recovery
Figure 87 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR%): “W” Shaped Recovery
Figure 88 Global Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR%): “L” Shaped Recovery
Figure 89 North America Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 90 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 91 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 92 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 93 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 94 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 95 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 96 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 97 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 98 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 99 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 100 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 101 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 102 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 103 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 104 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 105 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 106 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 107 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 108 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 109 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 110 North America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 111 North America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 112 North America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 113 North America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 114 North America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 115 U.S. Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 116 Canada Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 117 Europe Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 118 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 119 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 120 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 121 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 122 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 123 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 124 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 125 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 126 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 127 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 128 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 129 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 130 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 131 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 132 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 133 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 134 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 135 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 136 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 137 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 138 Europe Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 139 Europe Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 140 Europe Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 141 Europe Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 142 Europe Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 143 Germany Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 144 UK Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 145 France Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 146 Italy Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 147 Spain Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 148 Russia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 149 Rest of Europe Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 150 Asia Pacific Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 151 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 152 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 153 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 154 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 155 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 156 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 157 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 158 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 159 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 160 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 161 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 162 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 163 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 164 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 165 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 166 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 167 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 168 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 169 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 170 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 171 Asia Pacific Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 172 Asia Pacific Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 173 Asia Pacific Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 174 Asia Pacific Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 175 Asia Pacific Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 176 Japan Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 177 China Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 178 India Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 179 Australia Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 180 South Korea Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 181 Rest of Asia Pacific Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 182 Latin America Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 183 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 184 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 185 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 186 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 187 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 188 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 189 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 190 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 191 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 192 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 193 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 194 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 195 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 196 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 197 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 198 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 199 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 200 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 201 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 202 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 203 Latin America Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 204 Latin America Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 205 Latin America Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 206 Latin America Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 207 Latin America Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 208 Brazil Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 209 Mexico Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 210 Rest of Latin America Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 211 MEA Cellular Immunotherapy Market Forecast 2021-2031 (US$ billion, AGR%)
Figure 212 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 213 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 214 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 215 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 216 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 217 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 218 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 219 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 220 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 221 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 222 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 223 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 224 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 225 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 226 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 227 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 228 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 229 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 230 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 231 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 232 MEA Cellular Immunotherapy Market Forecast by Country 2021-2031 (US$ billion)
Figure 233 MEA Cellular Immunotherapy Market Forecast by Therapy Type, 2021-2031 (US$ billion)
Figure 234 MEA Cellular Immunotherapy Market Forecast by Product & Service, 2021-2031 (US$ billion)
Figure 235 MEA Cellular Immunotherapy Market Forecast by Testing Assays Type, 2021-2031 (US$ billion)
Figure 236 MEA Cellular Immunotherapy Market Forecast by Indication, 2021-2031 (US$ billion)
Figure 237 South Africa Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 238 GCC Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 239 Rest of MEA Cellular Immunotherapy Market Forecast, 2021-2031 (US$ billion, AGR %)
Figure 240 Cellular Immunotherapy Market: Company Share Analysis, 2020
Figure 241 Novartis AG: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 242 Novartis AG: Business Segments Revenue Shares, 2020
Figure 243 Novartis AG: Pharmaceuticals Business Unit Revenue Shares, 2020
Figure 244 Novartis AG: Regional Revenue Shares, 2020
Figure 245 Gilead Sciences, Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 246 Gilead Sciences, Inc.: Business Segments Revenue Shares, 2020
Figure 247 Gilead Sciences, Inc.: Regional Revenue Shares, 2020
Figure 248 Adicet Bio: Net Revenue, 2016-2020 (US$ Million, AGR%)
Figure 249 GlaxoSmithKline plc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 250 GlaxoSmithKline plc.: Pharmaceutical Business Revenue Shares, 2020
Figure 251 GlaxoSmithKline plc.: Regional Revenue Shares, 2020
Figure 252 Pfizer Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 253 Pfizer Inc.: Product Segment Revenue Shares, 2020
Figure 254 Pfizer Inc.: Regional Segment Revenue Shares, 2020
Figure 255 F. Hoffmann-La Roche Ltd.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 256 F. Hoffmann-La Roche Ltd.: Product Revenue Shares, 2020
Figure 257 F. Hoffmann-La Roche Ltd.: Regional Revenue Shares, 2020
Figure 258 Inovio Pharmaceuticals, Inc.: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 259 AstraZeneca: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 260 AstraZeneca: Product Revenue Shares, 2020
Figure 261 AstraZeneca: Regional Revenue Shares, 2020
Figure 262 Adaptimmune Therapeutics plc.: Net Revenue, 2016-2020 (US$ million, AGR%)
Figure 263 Bristol-Myers Squibb Company: Net Revenue, 2016-2020 (US$ billion, AGR%)
Figure 264 Bristol-Myers Squibb Company: Regional Revenue Shares, 2020
Figure 265 Global Cellular Immunotherapy Market Share Forecast by Therapy Type, 2021, 2026, 2031 (%)
Figure 266 Global Cellular Immunotherapy Market Share Forecast by Region, 2021, 2026, 2031 (%)
Companies Profiled in the Report
Adaptimmune Therapeutics plc.
Adicet Bio
APAC Biotech
AstraZeneca
Atara Biotherapeutics, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Inovio Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc.
JW Shinyak (JW CreaGene)
Novartis AG
Pfizer Inc.
Tessa Therapeutics Ltd.
List of Companies Mentioned in the Report
Abingworth
Acorn Campus Ventures
Adaptimmune
AFA Försäkring
AGF Private Equity
AgonOx
Agreen Biotech
Aju IB Investment
Alaska Permanent Fund
Alexandria Ventures
Allos Therapeutics
Altor BioScience
Amgen
Applied Immune Technologies
Aquilo Capital Management
ARCH Venture Partners
Artax Biopharma
AstraZeneca
Atara Biotherapeutics
Atlas Venture
Autolus (spin off from UCL)
AVG Ventures
Banca Esperia
BankInvest Biomedical Venture
Bayer
Baylor College of Medicine
Bellicum Pharmaceuticals
Bezos Expeditions
Biogen
BioNTech
Biotecnol
bluebird bio
Bpifrance
Brace Pharma Capital
Bristol-Myers Squibb
Broad Institute
Broadfin Capital
Cabaret Biotech
California Institute for Regenerative Medicine
California Institute of Technology
California Stem Cell Agency
Cancer Prevention and Research Institute of Texas
Caribou Sciences
CARsgen
Casdin Capital
Catalyst
Celdara
Celgene
Cell Therapy Catapult
Cellectis
CELLforCURE
Cellular Biomedicine Group
Cellular Therapeutics
Celyad
Children with Leukaemia
Chinese PLA General Hospital
City of Hope Medical Center
CLL Global Research Foundation Alliance
Cold Genesys
Conkwest
Cowen Investment
CRISPR Therapeutics
CrunchFund
Cyto Pulse
Dartmouth College
Deerfield Partners
Dendreon Corporation
Deutsche Krebshilfe
Duke University
Easton Capital
EcoR1 Capital
Editas Medicine
Edmond Venture Capital
Ehime University
Eisai
Eli Lilly
Endocyte
Erasmus University
Eureka Therapeutics
Fate Therapeutics
Felicis Ventures
Fidelity Biosciences
Fiverings Co.
Flagship Ventures
Forbion Capital Partners
Foresite Capital
Formula Pharmaceuticals
Fred Hutchinson Cancer Research Center
Fujita Health University
GammaCell Biotechnologies
Genentech
Genzyme (Sanofi)
Genzyme Ventures
Gilead Sciences
GlaxoSmithKline
Google Ventures
Griffin Securities
H. Lee Moffitt Cancer Center and Research Institute
Harbinger Venture Capital
Harvard University
Healthcare investment company Syncona
Heat Biologics
Herlev Hospital
High Line Venture Partners
ImmunoCellular Therapeutics
Immunocore
Imperial Innovations
IMS Health Capital
Innovative Genome Initiative
Intellia Therapeutics
Intrexon
Iowa State University
Jannsen Biotech
Jennison Associates
Jichi Medical University
JMP Securities
John Hopkins University
John Wayne Cancer Institute
Jonsson Comprehensive Cancer Center
JP Moulton Charitable Foundation
Juno Therapeutics
Karolinska University Hospital
Keio University, School of Medicine
Khosla Ventures
Kite Pharma
Leiden University Medical Center
Leukemia and Lymphoma Society
Ligand Pharmaceuticals
Lion Biotechnologies
Lonza Biologics
Loyola University
M.D. Anderson Cancer Center
Massachusetts Institute of Technology
MaxCyte
Mayo Clinic
Medigene
Memorial Sloan Kettering Cancer Center
Merck
Merck Serono
Mie University
Millennium Pharmaceuticals
MolMed
Monash University
Morphotek
Mustang Therapeutics
Nagoya University
Nantes University Hospital
Nantworks
National Cancer Institute
National Institute of Health
National University of Singapore
NeoStem
New Enterprise Associates (NEA)
New Leaf Venture
Novartis
Novartis Institute for Biomedical Research (NIBR)
Novo A/S
Oberland Capital Healthcare
ODYSSEE Venture
Ohio University
Omega Funds
Oncodesign Biotechnology
OnCyte
Ono Pharmaceutical Co.
Onyx Pharmaceuticals
Opexa Therapeutics
Opus Bio
OrbiMed Advisors
Oxford BioMedica
Partners Innovation Fund
Pasteur Institute
Peking University
Perceptive Advisors
Perelman School of Medicine, University of Pennsylvania
Peter MacCallum Cancer Centre, University of Melbourne
Pfizer
Pharmacyclics
Polaris Partners
Pontifax
Precision Biosciences/Pregenen
Precision Genome Engineering
Progenitor Cell Therapy
Pure MHC
QueensBridge Venture Partners
Quogue Capital
QVT Financial
RA capital Management
Ramius Capital Group
Redmile Group
Remeditex Ventures
Renji Hospital
Ridgeway Capital Partners
Riverbank Capital Securities
Roche
Rock Spring Capital
Roswell Park Cancer Institute
Sabby Capital
San Raffaele Hospital (OSR)
Sanderling Ventures
Sangamo Biosciences
Sanofi-Genzyme BioVentures
Seattle Children's Hospital
Seattle Genetics
Sectoral Asset Management
Servier
Shanghai Cancer Institute
Sheba Medical Center
Shenzhen Second People's Hospital
Shionogi
Silicon Valley Bank
Sorrento Therapeutics
Southwest Hospital
Spectrum Pharmaceuticals
SR One
St. Jude Children’s Research Hospital
Stage Cell Therapeutics
Statcom Co.
Suma Ventures
Sun Yat-Sen University
Sunol Molecular Corporation
SV Angel
Swedish Cancer Society
T-Cell Factory
T. Rowe Price Associates
Takara Bio
Tel Aviv Sourasky Medical Centre
TETHYS
Texas Children's Hospital
The Children's Hospital of Philadelphia
The Christie NHS Foundation Trust
The Methodist Hospital System
The Netherlands Cancer Institute
Theravectys
Thermo Fisher Scientific
Third Rock Ventures
Three Arch Opportunity Fund
TILT Biotherapeutics
TNK Therapeutics (wholly owned subsidiary of Sorrento Therapeutics)
Transposagen Biopharmaceuticals
TVM Capital
Two Blades Foundation
TxCell
University College of London
University Health Network
University of California
University of Connecticut
University of Florida
University of Milano-Bicocca
University of Minnesota
University of Oxford
University of Southern California
University of Zurich
Unum Therapeutics
Uppsala University
Valeant Pharmaceuticals
venBio
Venrock
Versant Ventures
Viking Global Investors
Weill Cornell Medical College
Weizmann Institute of Science
Wellington Management
X-Body
Y Combinator
Yuan Capital
ZIOPHARM Oncology
List of Organizations Mentioned in the Report
ACRF Centre for Advanced Cellular Immunotherapy
Agencia Nacional de Vigiloncia Sanitaria (ANVISA)
American Cancer Society (ACS)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center of Excellence in Immunology (CEI)
Centers for Disease Control and Prevention (CDC)
Centers for Medicare & Medicaid Services programs
European Medicines Agency (EMA)
European Union
Experimental Transplantation & Immunotherapy Branch at CCR
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
International Agency for Research on Cancer (IARC)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Laboratory of Tumor Immunology and Biology at CCR
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare (MHLW)
National Cancer Institute (NCI)
National Cancer Institute's Center for Cancer Research (CCR)
National Development and Reform Commission (NDRC)
National Institutes of Health (NIH)
NCBI
NCI's Division of Cancer Biology's Cancer Immunology, Hematology, and Etiology Branch (CIHEB)
The Therapeutic Goods Administration
United Nations (UN)
University of Connecticut
World Health Organization (WHO)
World Population Prospects
Adaptimmune Therapeutics plc.
Adicet Bio
APAC Biotech
AstraZeneca
Atara Biotherapeutics, Inc.
Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc.
GlaxoSmithKline plc.
Inovio Pharmaceuticals, Inc.
Iovance Biotherapeutics, Inc.
JW Shinyak (JW CreaGene)
Novartis AG
Pfizer Inc.
Tessa Therapeutics Ltd.
List of Companies Mentioned in the Report
Abingworth
Acorn Campus Ventures
Adaptimmune
AFA Försäkring
AGF Private Equity
AgonOx
Agreen Biotech
Aju IB Investment
Alaska Permanent Fund
Alexandria Ventures
Allos Therapeutics
Altor BioScience
Amgen
Applied Immune Technologies
Aquilo Capital Management
ARCH Venture Partners
Artax Biopharma
AstraZeneca
Atara Biotherapeutics
Atlas Venture
Autolus (spin off from UCL)
AVG Ventures
Banca Esperia
BankInvest Biomedical Venture
Bayer
Baylor College of Medicine
Bellicum Pharmaceuticals
Bezos Expeditions
Biogen
BioNTech
Biotecnol
bluebird bio
Bpifrance
Brace Pharma Capital
Bristol-Myers Squibb
Broad Institute
Broadfin Capital
Cabaret Biotech
California Institute for Regenerative Medicine
California Institute of Technology
California Stem Cell Agency
Cancer Prevention and Research Institute of Texas
Caribou Sciences
CARsgen
Casdin Capital
Catalyst
Celdara
Celgene
Cell Therapy Catapult
Cellectis
CELLforCURE
Cellular Biomedicine Group
Cellular Therapeutics
Celyad
Children with Leukaemia
Chinese PLA General Hospital
City of Hope Medical Center
CLL Global Research Foundation Alliance
Cold Genesys
Conkwest
Cowen Investment
CRISPR Therapeutics
CrunchFund
Cyto Pulse
Dartmouth College
Deerfield Partners
Dendreon Corporation
Deutsche Krebshilfe
Duke University
Easton Capital
EcoR1 Capital
Editas Medicine
Edmond Venture Capital
Ehime University
Eisai
Eli Lilly
Endocyte
Erasmus University
Eureka Therapeutics
Fate Therapeutics
Felicis Ventures
Fidelity Biosciences
Fiverings Co.
Flagship Ventures
Forbion Capital Partners
Foresite Capital
Formula Pharmaceuticals
Fred Hutchinson Cancer Research Center
Fujita Health University
GammaCell Biotechnologies
Genentech
Genzyme (Sanofi)
Genzyme Ventures
Gilead Sciences
GlaxoSmithKline
Google Ventures
Griffin Securities
H. Lee Moffitt Cancer Center and Research Institute
Harbinger Venture Capital
Harvard University
Healthcare investment company Syncona
Heat Biologics
Herlev Hospital
High Line Venture Partners
ImmunoCellular Therapeutics
Immunocore
Imperial Innovations
IMS Health Capital
Innovative Genome Initiative
Intellia Therapeutics
Intrexon
Iowa State University
Jannsen Biotech
Jennison Associates
Jichi Medical University
JMP Securities
John Hopkins University
John Wayne Cancer Institute
Jonsson Comprehensive Cancer Center
JP Moulton Charitable Foundation
Juno Therapeutics
Karolinska University Hospital
Keio University, School of Medicine
Khosla Ventures
Kite Pharma
Leiden University Medical Center
Leukemia and Lymphoma Society
Ligand Pharmaceuticals
Lion Biotechnologies
Lonza Biologics
Loyola University
M.D. Anderson Cancer Center
Massachusetts Institute of Technology
MaxCyte
Mayo Clinic
Medigene
Memorial Sloan Kettering Cancer Center
Merck
Merck Serono
Mie University
Millennium Pharmaceuticals
MolMed
Monash University
Morphotek
Mustang Therapeutics
Nagoya University
Nantes University Hospital
Nantworks
National Cancer Institute
National Institute of Health
National University of Singapore
NeoStem
New Enterprise Associates (NEA)
New Leaf Venture
Novartis
Novartis Institute for Biomedical Research (NIBR)
Novo A/S
Oberland Capital Healthcare
ODYSSEE Venture
Ohio University
Omega Funds
Oncodesign Biotechnology
OnCyte
Ono Pharmaceutical Co.
Onyx Pharmaceuticals
Opexa Therapeutics
Opus Bio
OrbiMed Advisors
Oxford BioMedica
Partners Innovation Fund
Pasteur Institute
Peking University
Perceptive Advisors
Perelman School of Medicine, University of Pennsylvania
Peter MacCallum Cancer Centre, University of Melbourne
Pfizer
Pharmacyclics
Polaris Partners
Pontifax
Precision Biosciences/Pregenen
Precision Genome Engineering
Progenitor Cell Therapy
Pure MHC
QueensBridge Venture Partners
Quogue Capital
QVT Financial
RA capital Management
Ramius Capital Group
Redmile Group
Remeditex Ventures
Renji Hospital
Ridgeway Capital Partners
Riverbank Capital Securities
Roche
Rock Spring Capital
Roswell Park Cancer Institute
Sabby Capital
San Raffaele Hospital (OSR)
Sanderling Ventures
Sangamo Biosciences
Sanofi-Genzyme BioVentures
Seattle Children's Hospital
Seattle Genetics
Sectoral Asset Management
Servier
Shanghai Cancer Institute
Sheba Medical Center
Shenzhen Second People's Hospital
Shionogi
Silicon Valley Bank
Sorrento Therapeutics
Southwest Hospital
Spectrum Pharmaceuticals
SR One
St. Jude Children’s Research Hospital
Stage Cell Therapeutics
Statcom Co.
Suma Ventures
Sun Yat-Sen University
Sunol Molecular Corporation
SV Angel
Swedish Cancer Society
T-Cell Factory
T. Rowe Price Associates
Takara Bio
Tel Aviv Sourasky Medical Centre
TETHYS
Texas Children's Hospital
The Children's Hospital of Philadelphia
The Christie NHS Foundation Trust
The Methodist Hospital System
The Netherlands Cancer Institute
Theravectys
Thermo Fisher Scientific
Third Rock Ventures
Three Arch Opportunity Fund
TILT Biotherapeutics
TNK Therapeutics (wholly owned subsidiary of Sorrento Therapeutics)
Transposagen Biopharmaceuticals
TVM Capital
Two Blades Foundation
TxCell
University College of London
University Health Network
University of California
University of Connecticut
University of Florida
University of Milano-Bicocca
University of Minnesota
University of Oxford
University of Southern California
University of Zurich
Unum Therapeutics
Uppsala University
Valeant Pharmaceuticals
venBio
Venrock
Versant Ventures
Viking Global Investors
Weill Cornell Medical College
Weizmann Institute of Science
Wellington Management
X-Body
Y Combinator
Yuan Capital
ZIOPHARM Oncology
List of Organizations Mentioned in the Report
ACRF Centre for Advanced Cellular Immunotherapy
Agencia Nacional de Vigiloncia Sanitaria (ANVISA)
American Cancer Society (ACS)
Center for Biologics Evaluation and Research (CBER)
Center for Devices and Radiological Health (CDRH)
Center of Excellence in Immunology (CEI)
Centers for Disease Control and Prevention (CDC)
Centers for Medicare & Medicaid Services programs
European Medicines Agency (EMA)
European Union
Experimental Transplantation & Immunotherapy Branch at CCR
Food and Drug Administration (FDA)
French Government
Government of Japan
Health Ministry (Italy)
Indian Council of Medical Research (ICMR)
Institute for Healthcare Improvement (IHI)
International Agency for Research on Cancer (IARC)
Italian Industry Group Farmindustria
Japanese Ministry of Health, Labour and Welfare
Laboratory of Tumor Immunology and Biology at CCR
Medicines and Healthcare Products Regulatory Agency (MHRA)
Ministry of Health, Labour & Welfare (MHLW)
National Cancer Institute (NCI)
National Cancer Institute's Center for Cancer Research (CCR)
National Development and Reform Commission (NDRC)
National Institutes of Health (NIH)
NCBI
NCI's Division of Cancer Biology's Cancer Immunology, Hematology, and Etiology Branch (CIHEB)
The Therapeutic Goods Administration
United Nations (UN)
University of Connecticut
World Health Organization (WHO)
World Population Prospects
Download sample pages
Complete the form below to download your free sample pages for Cellular Immunotherapy Market Report 2021-2031Related reports
-
Global Stem Cell Technologies and Applications Market 2020-2030
The global stem cell technologies and applications market is estimated to have reached US $17,791.8 million 2020 and is expected...
Full DetailsPublished: 24 March 2020 -
Vaccine Contract Manufacturing Market Forecast 2020-2030
The global vaccine contract manufacturing market was worth $2,241.6m in 2019 and is expected to grow at a CAGR of...
Full DetailsPublished: 08 April 2020 -
Allergic Rhinitis Drugs Market Report 2023-2033
The global Allergic Rhinitis Drugs market is projected to grow at a CAGR of 3.78% by 2033...Full DetailsPublished: 30 January 2023 -
Gene Therapy R&D and Revenue Forecasts 2020-2030
The gene therapy market is projected to grow at a CAGR of 32% in the first half of the forecast...
Full DetailsPublished: 06 March 2020 -
Influenza Vaccines Market Report 2020-2030
For the companies operating in the global influenza vaccines market, there is an immense opportunity from emerging economies across the...Full DetailsPublished: 30 September 2020 -
ePharmacy Market Report 2021-2031
The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and...Full DetailsPublished: 19 April 2021 -
Vaccines Sales Market Report 2020-2030
Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New...
Full DetailsPublished: 10 September 2020
Download sample pages
Complete the form below to download your free sample pages for Cellular Immunotherapy Market Report 2021-2031Do you have any custom requirements we can help you with?
Any specific country, geo region, market segment or specific company information?
Email us today, we can discuss your needs and see how we can help: jamie.roberts@visiongain.com
Would you like a free report overview of the report of your choice?
If so, please drop an email to Jamie Roberts stating your chosen report title to jamie.roberts@visiongain.com
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email jamie.roberts@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.”
Dr Luz Chapa Azuella, Mexico
American Association of Colleges of Pharmacy
American College of Clinical Pharmacy
American Pharmacists Association
American Society for Pharmacy Law
American Society of Consultant Pharmacists
American Society of Health-System Pharmacists
Association of Special Pharmaceutical Manufacturers
Australian College of Pharmacy
Biotechnology Industry Organization
Canadian Pharmacists Association
Canadian Society of Hospital Pharmacists
Chinese Pharmaceutical Association
College of Psychiatric and Neurologic Pharmacists
Danish Association of Pharmaconomists
European Association of Employed Community Pharmacists in Europe
European Medicines Agency
Federal Drugs Agency
General Medical Council
Head of Medicines Agency
International Federation of Pharmaceutical Manufacturers & Associations
International Pharmaceutical Federation
International Pharmaceutical Students’ Federation
Medicines and Healthcare Products Regulatory Agency
National Pharmacy Association
Norwegian Pharmacy Association
Ontario Pharmacists Association
Pakistan Pharmacists Association
Pharmaceutical Association of Mauritius
Pharmaceutical Group of the European Union
Pharmaceutical Society of Australia
Pharmaceutical Society of Ireland
Pharmaceutical Society Of New Zealand
Pharmaceutical Society of Northern Ireland
Professional Compounding Centers of America
Royal Pharmaceutical Society
The American Association of Pharmaceutical Scientists
The BioIndustry Association
The Controlled Release Society
The European Federation of Pharmaceutical Industries and Associations
The European Personalised Medicine Association
The Institute of Clinical Research
The International Society for Pharmaceutical Engineering
The Pharmaceutical Association of Israel
The Pharmaceutical Research and Manufacturers of America
The Pharmacy Guild of Australia
The Society of Hospital Pharmacists of Australia
Visiongain Pharma
Visiongain Pharma
Visiongain PharmaLatest Pharma news
Visiongain Publishes Drug Delivery Technologies Market Report 2024-2034
The global Drug Delivery Technologies market is estimated at US$1,729.6 billion in 2024 and is projected to grow at a CAGR of 5.5% during the forecast period 2024-2034.
23 April 2024
Visiongain Publishes Cell Therapy Technologies Market Report 2024-2034
The cell therapy technologies market is estimated at US$7,041.3 million in 2024 and is projected to grow at a CAGR of 10.7% during the forecast period 2024-2034.
18 April 2024
Visiongain Publishes Automation in Biopharma Industry Market Report 2024-2034
The global Automation in Biopharma Industry market is estimated at US$1,954.3 million in 2024 and is projected to grow at a CAGR of 7% during the forecast period 2024-2034.
17 April 2024
Visiongain Publishes Anti-obesity Drugs Market Report 2024-2034
The global Anti-obesity Drugs market is estimated at US$11,540.2 million in 2024 and is expected to register a CAGR of 21.2% from 2024 to 2034.
12 April 2024
